Zobrazeno 1 - 10
of 162
pro vyhledávání: '"T. P. van Staa"'
Autor:
T P van Staa, I. J. A. de Bruin, Patrick C. Souverein, J. van den Bergh, Caroline E. Wyers, F. de Vries, Johanna H M Driessen, Piet Geusens
Publikováno v:
de Bruin, I J A, Wyers, C E, Souverein, P C, van Staa, T P, Geusens, P P M M, van den Bergh, J P W, de Vries, F & Driessen, J H M 2020, ' The risk of new fragility fractures in patients with chronic kidney disease and hip fracture-a population-based cohort study in the UK ', Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA . https://doi.org/10.1007/s00198-020-05351-x
Osteoporosis International, 31(8), 1487-1497. Springer-Verlag London Ltd.
Osteoporosis International
Osteoporosis International, 31(8), 1487. Springer London
Osteoporosis International, 31(8), 1487-1497. Springer-Verlag London Ltd.
Osteoporosis International
Osteoporosis International, 31(8), 1487. Springer London
Summary Chronic kidney disease (CKD) is a risk factor for fractures. However, in hip fracture patients, CKD G3-G5 was associated with a higher mortality risk and not associated with a higher risk of subsequent non-hip fractures compared to eGFR > 60
Autor:
S, Khalid, S, Calderon-Larranaga, A, Sami, S, Hawley, A, Judge, N, Arden, T P, Van Staa, C, Cooper, B, Abrahamsen, M Kassim, Javaid, D, Prieto-Alhambra
Publikováno v:
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 33(7)
The aim of this study was to evaluate the risk of acute myocardial infarction in patients taking osteoporosis medication. Patients were taken from the SIDIAP or CPRD database and were matched using propensity scores. Patients with diabetes and chroni
Autor:
F. de Vries, Nicholas C. Harvey, C Cooper, J. van den Bergh, Caroline E. Wyers, R. Y. van der Velde, Piet Geusens, T P van Staa
Publikováno v:
Van Der Velde, R Y, Wyers, C E, Geusens, P P M M, Van Den Bergh, J P W, De Vries, F, Cooper, C, Van De Staa, T P & Harvey, N C 2018, ' Incidence of subsequent fractures in the UK between 1990 and 2012 among individuals 50 years or older ', Osteoporosis International, vol. 29, no. 11, pp. 2469-2475 . https://doi.org/10.1007/s00198-018-4636-0
Osteoporosis International, 29(11), 2469-2475. Springer-Verlag London Ltd.
Osteoporosis International, 29. Springer London
Osteoporosis International, 29(11), 2469-2475. Springer-Verlag London Ltd.
Osteoporosis International, 29. Springer London
SummaryWe studied the incidence of subsequent fractures in persons of 50+ years from 1990 to 2012 and the relative risk (RR) of subsequent fractures after an index femur/hip fracture, stratified per 5-year age band. Patients suffering a fracture have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7d72442de3a1458ac9a82a36fa130e6
http://www.scopus.com/inward/record.url?scp=85050271061&partnerID=8YFLogxK
http://www.scopus.com/inward/record.url?scp=85050271061&partnerID=8YFLogxK
Autor:
Daniel Prieto-Alhambra, Irene Petersen, Antonella Delmestri, Cyrus Cooper, T P van Staa, Samuel Hawley, Muhammad Javaid, Elisa Martín-Merino, S Khalid, Ana Llorente-García, Arturo Álvarez-Gutiérrez, Andrew Judge
Publikováno v:
Martín-Merino, E, Petersen, I, Hawley, S, Álvarez-Gutierrez, A, Khalid, S, Llorente-Garcia, A, Delmestri, A, Javaid, M K, Van Staa, T P, Judge, A, Cooper, C & Prieto-Alhambra, D 2018, ' Risk of venous thromboembolism among users of different anti-osteoporosis drugs : a population-based cohort analysis including over 200,000 participants from Spain and the UK ', Osteoporosis International, vol. 29, no. 2, pp. 467–478 . https://doi.org/10.1007/s00198-017-4308-5
Osteoporosis International, 29(2), 467. Springer London
Osteoporosis International, 29(2), 467. Springer London
Summary: The venous thromboembolism risk among anti-osteoporotics is unknown. In this primary care study, the risk with other bisphosphonates [1.05 (0.94–1.18) and 0.96 (0.78–1.18)], strontium [0.90 (0.61–1.34) and 1.19 (0.82–1.74)], in the U
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61ea1c66acd73521280d5a741fc8a6b8
https://research-information.bris.ac.uk/en/publications/96424aca-97f6-4f82-9a2c-17ac31191ef6
https://research-information.bris.ac.uk/en/publications/96424aca-97f6-4f82-9a2c-17ac31191ef6
Autor:
Daniel Prieto-Alhambra, S Khalid, Nigel K Arden, T P van Staa, M S Ali, C Cooper, Muhammad Javaid, Andrew Judge, Samuel Hawley, S Calderon
Publikováno v:
Rheumatology. 56
Autor:
Nigel K Arden, M S Ali, C Cooper, Andrew Judge, S Khalid, T P van Staa, Daniel Prieto-Alhambra, Samuel Hawley, Muhammad Javaid
Publikováno v:
Rheumatology. 56
Autor:
T P van Staa, J. van den Bergh, E. Teesselink, F. de Vries, Nicholas C. Harvey, Caroline E. Wyers, R. Y. van der Velde, Piet Geusens, Cyrus Cooper
Publikováno v:
Bone, 94, 50. Elsevier
Bone, 94, 50-55. Elsevier Science
Bone, 94, 50-55. Elsevier Science
Introduction: Given the expected increase in the number of patients with osteoporosis and fragility fractures it is important to have concise information on trends in prescription rates of anti-osteoporosis drugs (AOD). Methods: We undertook a retros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0d9dd710cfbdeae4fd409fe7ca2cb15
https://ora.ox.ac.uk/objects/uuid:f72940b4-d6c9-4628-bfeb-426e021a467f
https://ora.ox.ac.uk/objects/uuid:f72940b4-d6c9-4628-bfeb-426e021a467f
Autor:
T P van Staa, Andrea L. Jorgensen, J Campbell, Daniel F. Carr, Gerry P McCann, M Hobbs, Munir Pirmohamed, Helen O'Meara
Publikováno v:
Clinical Pharmacology and Therapeutics
This study aimed to determine whether patients with statin-induced myopathy could be identified using the United Kingdom Clinical Practice Research Datalink, whether DNA could be obtained, and whether previously reported associations of statin myopat
Publikováno v:
Journal of Thrombosis and Haemostasis. 11:107-115
Summary. Background: Anticoagulation control is often summarized using the percentage of time spent in a therapeutic range (TTR). This method does not describe the timing and severity of fluctuations in the International Normalised Ratio (INR).Object
Autor:
DV Oksen, Emanuele Lettieri, M Nikolski, Paolo Bertele, Pierre Verger, A Cambon-Thomsen, J-C Dufour, T P van Staa, Thomas Ganslandt, Wolfgang Kuchinke, Anita Burgun, ML Gjerstorff, Christian Ohmann, Geneviève Chêne, Cristina Masella, J-F Gibrat, C Persoz, M Salokannel, James A. Cunningham, H-U Prokosch, Rodolphe Thiébaut, Iain Buchan
Publikováno v:
Meeting abstract
9. European Public Health Conference
9. European Public Health Conference, Nov 2016, Vienne, Austria. ⟨10.1093/eurpub/ckw168.038⟩
9. European Public Health Conference
9. European Public Health Conference, Nov 2016, Vienne, Austria. ⟨10.1093/eurpub/ckw168.038⟩
Linking health and administrative data for maternal, child and young adult health. 9. European Public Health Conference
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddf3fd21b4aed8543a3ddafa04277047
https://hal.archives-ouvertes.fr/hal-01861720
https://hal.archives-ouvertes.fr/hal-01861720